Literature DB >> 32421370

CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice.

Stefanie Y Tan1,2, Xia Lei1,2, Hannah C Little1,2, Susana Rodriguez1,2, Dylan C Sarver1,2, Xi Cao1,2,3, G William Wong1,2.   

Abstract

Secreted hormones facilitate tissue cross talk to maintain energy balance. We previously described C1q/TNF-related protein 12 (CTRP12) as a novel metabolic hormone. Gain-of-function and partial-deficiency mouse models have highlighted important roles for this fat-derived adipokine in modulating systemic metabolism. Whether CTRP12 is essential and required for metabolic homeostasis is unknown. We show here that homozygous deletion of Ctrp12 gene results in sexually dimorphic phenotypes. Under basal conditions, complete loss of CTRP12 had little impact on male mice, whereas it decreased body weight (driven by reduced lean mass and liver weight) and improved insulin sensitivity in female mice. When challenged with a high-fat diet, Ctrp12 knockout (KO) male mice had decreased energy expenditure, increased weight gain and adiposity, elevated serum TNFα level, and reduced insulin sensitivity. In contrast, female KO mice had reduced weight gain and liver weight. The expression of lipid synthesis and catabolism genes, as well as profibrotic, endoplasmic reticulum stress, and oxidative stress genes were largely unaffected in the adipose tissue of Ctrp12 KO male mice. Despite greater adiposity and insulin resistance, Ctrp12 KO male mice fed an obesogenic diet had lower circulating triglyceride and free fatty acid levels. In contrast, lipid profiles of the leaner female KO mice were not different from those of WT controls. These data suggest that CTRP12 contributes to whole body energy metabolism in genotype-, diet-, and sex-dependent manners, underscoring complex gene-environment interactions influencing metabolic outcomes.

Entities:  

Keywords:  C1q/TNF-related protein; CTRP12; diabetes; insulin resistance; lipid metabolism; obesity; secreted hormone

Mesh:

Substances:

Year:  2020        PMID: 32421370      PMCID: PMC7468785          DOI: 10.1152/ajpendo.00533.2019

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  94 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

Authors:  C T Montague; J B Prins; L Sanders; J E Digby; S O'Rahilly
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

3.  Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism.

Authors:  Takashi Enomoto; Koji Ohashi; Rei Shibata; Akiko Higuchi; Sonomi Maruyama; Yasuhiro Izumiya; Kenneth Walsh; Toyoaki Murohara; Noriyuki Ouchi
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

4.  Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality.

Authors:  H A Heilstedt; B C Ballif; L A Howard; C D Kashork; L G Shaffer
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

Review 5.  Direct effects of sex steroid hormones on adipose tissues and obesity.

Authors:  J S Mayes; G H Watson
Journal:  Obes Rev       Date:  2004-11       Impact factor: 9.213

6.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.

Authors:  Terry P Combs; Anders H Berg; Michael W Rajala; Simon Klebanov; Puneeth Iyengar; José C Jimenez-Chillaron; Mary Elizabeth Patti; Sabra L Klein; Robert S Weinstein; Philipp E Scherer
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

7.  Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway.

Authors:  Bee K Tan; Jing Chen; Raghu Adya; Manjunath Ramanjaneya; Vanlata Patel; Harpal S Randeva
Journal:  J Endocrinol       Date:  2013-10-04       Impact factor: 4.286

Review 8.  Copy number variants in obesity-related syndromes: review and perspectives on novel molecular approaches.

Authors:  Carla Sustek D'Angelo; Celia Priszkulnik Koiffmann
Journal:  J Obes       Date:  2012-12-17

Review 9.  Sex-specific differences in lipid and glucose metabolism.

Authors:  Oleg Varlamov; Cynthia L Bethea; Charles T Roberts
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-19       Impact factor: 5.555

10.  Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans.

Authors:  K Verboven; K Wouters; K Gaens; D Hansen; M Bijnen; S Wetzels; C D Stehouwer; G H Goossens; C G Schalkwijk; E E Blaak; J W Jocken
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

View more
  5 in total

1.  CTRP6 rapidly responds to acute nutritional changes, regulating adipose tissue expansion and inflammation in mice.

Authors:  Rotem Lahav; Yulia Haim; Nikhil S Bhandarkar; Liron Levin; Vered Chalifa-Caspi; Dylan Sarver; Ageline Sahagun; Nitzan Maixner; Barr Kovesh; G William Wong; Assaf Rudich
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-11       Impact factor: 4.310

2.  CTRP14 inactivation alters physical activity and food intake response to fasting and refeeding.

Authors:  Dylan C Sarver; Cheng Xu; Susan Aja; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-04-11       Impact factor: 5.900

3.  CTRP11 contributes modestly to systemic metabolism and energy balance.

Authors:  Dylan C Sarver; Cheng Xu; Dana Carreno; Alexander Arking; Chantelle E Terrillion; Susan Aja; G William Wong
Journal:  FASEB J       Date:  2022-06       Impact factor: 5.834

4.  CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression.

Authors:  Stefanie Y Tan; Hannah C Little; Dylan C Sarver; Paul A Watkins; G William Wong
Journal:  FEBS Lett       Date:  2020-08-14       Impact factor: 4.124

5.  CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.

Authors:  Gang Wang; Jiao-Jiao Chen; Wen-Yi Deng; Kun Ren; Shan-Hui Yin; Xiao-Hua Yu
Journal:  Cell Death Dis       Date:  2021-03-10       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.